ZA943593B - Pharmaceutical composition of a 5-HT3 receptor antagonist for rectal administration - Google Patents

Pharmaceutical composition of a 5-HT3 receptor antagonist for rectal administration

Info

Publication number: ZA943593B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical composition; receptor antagonist; rectal administration; rectal; administration
Prior art date: 1993-05-25

Application number

ZA943593A

Other languages

English (en)

Inventor

Isabelle Thielemans

Isabelle Richard

Original Assignee

Glaxo Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-25

Filing date

1994-05-24

Publication date

1995-02-13

1994-05-24 Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa

1995-02-13 Publication of ZA943593B publication Critical patent/ZA943593B/xx

Links

229940113081 5 Hydroxytryptamine 3 receptor antagonist Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

ZA943593A 1993-05-25 1994-05-24 Pharmaceutical composition of a 5-HT3 receptor antagonist for rectal administration ZA943593B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939310756A GB9310756D0 (en)	1993-05-25	1993-05-25	Compositions

Publications (1)

Publication Number	Publication Date
ZA943593B true ZA943593B (en)	1995-02-13

Family

ID=10736089

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA943593A ZA943593B (en)	1993-05-25	1994-05-24	Pharmaceutical composition of a 5-HT3 receptor antagonist for rectal administration

Country Status (38)

Country	Link
US (1)	US5741806A (de)
EP (1)	EP0700290B1 (de)
JP (1)	JP2965703B2 (de)
KR (1)	KR100297212B1 (de)
CN (1)	CN1106194C (de)
AP (1)	AP544A (de)
AT (1)	ATE183643T1 (de)
AU (1)	AU680918B2 (de)
BE (1)	BE1007158A3 (de)
BR (1)	BR1100046A (de)
CA (1)	CA2162919C (de)
CO (1)	CO4230094A1 (de)
CY (1)	CY2411B1 (de)
CZ (1)	CZ291041B6 (de)
DE (1)	DE69420266T2 (de)
DK (1)	DK0700290T3 (de)
EC (1)	ECSP941088A (de)
ES (1)	ES2136198T3 (de)
FR (1)	FR2705569B1 (de)
GB (2)	GB9310756D0 (de)
GR (1)	GR3031669T3 (de)
HR (2)	HRP940315B1 (de)
HU (1)	HU227121B1 (de)
IE (1)	IE80632B1 (de)
IL (1)	IL109749A (de)
IS (1)	IS1868B (de)
IT (1)	IT1272990B (de)
MY (1)	MY111445A (de)
NO (1)	NO306448B1 (de)
NZ (1)	NZ267415A (de)
PE (1)	PE13395A1 (de)
PL (1)	PL175578B1 (de)
RU (1)	RU2132684C1 (de)
SA (1)	SA94150003B1 (de)
SG (1)	SG48119A1 (de)
SI (1)	SI0700290T1 (de)
WO (1)	WO1994027599A1 (de)
ZA (1)	ZA943593B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200103057T2 (tr)	1998-06-15	2002-06-21	Sepracor Inc.	Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı
EP1468685A3 (de) *	1998-06-15	2004-12-15	Sepracor Inc.	Verwendung von optisch reines (+)-Norcisapride für die Behandlung von Apnea, Bulimia und andere Krankheiten
EP1464333A3 (de) *	1998-06-15	2004-12-15	Sepracor Inc.	Verwendung von optisch reines (-) Norcisapride in der Behandlung von Apnea, Bulimia und andere Krankheiten
JP2003522103A (ja) *	1998-06-15	2003-07-22	セプラコアインコーポレーテッド	無呼吸、過食症およびその他の障害を治療するための光学的に純粋な（−）−ノルシスアプリドの使用
US6362202B1 (en)	1999-03-02	2002-03-26	Sepracor Inc.	Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en)	1999-03-02	2002-03-05	Sepracor, Inc.	Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
CN100553636C (zh) *	2000-08-04	2009-10-28	Dmi生物科学公司	二酮基哌嗪和包含它们的组合物的使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE460359B (sv) *	1984-01-25	1989-10-02	Glaxo Group Ltd	3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
US4695578A (en) *	1984-01-25	1987-09-22	Glaxo Group Limited	1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
GB8627909D0 (en) *	1986-11-21	1986-12-31	Glaxo Group Ltd	Medicaments
GB8816187D0 (en) *	1988-07-07	1988-08-10	Glaxo Group Ltd	Medicaments
GB8914804D0 (en) *	1989-06-28	1989-08-16	Glaxo Group Ltd	Process
US5166145A (en) *	1990-09-10	1992-11-24	Alza Corporation	Antiemetic therapy

1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
1994
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active Expired - Lifetime
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en not_active Ceased
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 EP EP94918355A patent/EP0700290B1/de not_active Expired - Lifetime
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown

Also Published As

Publication number	Publication date
GB9409835D0 (en)	1994-07-06
ITRM940322A0 (it)	1994-05-24
SG48119A1 (en)	1998-04-17
AU6970994A (en)	1994-12-20
HU227121B1 (en)	2010-07-28
PL175578B1 (pl)	1999-01-29
AU680918B2 (en)	1997-08-14
HRP940315B1 (en)	2000-12-31
NO954783D0 (no)	1995-11-24
NZ267415A (en)	1997-10-24
KR100297212B1 (ko)	2001-10-24
EP0700290A1 (de)	1996-03-13
US5741806A (en)	1998-04-21
HUT74867A (en)	1997-02-28
HU9503375D0 (en)	1996-01-29
PE13395A1 (es)	1995-05-25
SI0700290T1 (en)	1999-12-31
JPH08510457A (ja)	1996-11-05
CZ291041B6 (cs)	2002-12-11
DE69420266D1 (de)	1999-09-30
BE1007158A3 (fr)	1995-04-11
DK0700290T3 (da)	2000-03-13
CZ308595A3 (en)	1996-06-12
GB2279008A (en)	1994-12-21
JP2965703B2 (ja)	1999-10-18
CA2162919C (en)	1999-07-20
ATE183643T1 (de)	1999-09-15
IS1868B (is)	2003-05-02
CN1106194C (zh)	2003-04-23
NO954783L (no)	1995-11-24
AP544A (en)	1996-10-11
CN1124454A (zh)	1996-06-12
HRP940315A2 (en)	1996-08-31
GR3031669T3 (en)	2000-02-29
CO4230094A1 (es)	1995-10-19
IE80632B1 (en)	1998-10-21
HRP970315A2 (en)	1999-04-30
CA2162919A1 (en)	1994-12-08
GB9310756D0 (en)	1993-07-14
MY111445A (en)	2000-05-31
ITRM940322A1 (it)	1995-11-24
AP9400643A0 (en)	1994-07-31
IE940420A1 (en)	1994-11-30
FR2705569A1 (fr)	1994-12-02
BR1100046A (pt)	1999-11-23
IL109749A0 (en)	1994-08-26
WO1994027599A1 (en)	1994-12-08
GB2279008B (en)	1997-06-18
IL109749A (en)	1999-03-12
IS4168A (is)	1994-11-26
ECSP941088A (es)	1994-11-16
EP0700290B1 (de)	1999-08-25
DE69420266T2 (de)	1999-12-09
SA94150003B1 (ar)	2005-04-11
IT1272990B (it)	1997-07-01
ES2136198T3 (es)	1999-11-16
RU2132684C1 (ru)	1999-07-10
NO306448B1 (no)	1999-11-08
PL311721A1 (en)	1996-03-04
CY2411B1 (en)	2004-11-12
FR2705569B1 (fr)	1995-11-10

Publication	Publication Date	Title
EP0687472A3 (de)	1997-01-15	Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
GB9518113D0 (en)	1995-11-08	Polymorphic form of a tachykinin receptor antagonist
IL97513A0 (en)	1992-06-21	A pharmaceutical composition containing a thromboxane a2 receptor antagonist prostaglandin analog
HUP9603298A3 (en)	1999-10-28	Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, and their use for the preparation of pharmaceutical compositions
IL110503A (en)	2000-06-29	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation and pharmaceutical compositions containing them
IL111007A0 (en)	1994-11-28	Composition containing rapamycin for oral administration
HUP9701714A3 (en)	2000-03-28	Indole derivatives neuropeptide y receptor antagonists, use thereof and pharmaceutical compositions containing these compounds
HUP9901296A3 (en)	2001-01-29	Substituted piperidine derivatives as nmda receptor antagonists and pharmaceutical compositions containing them
EP0714663A3 (de)	1997-01-15	Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
IL131818A0 (en)	2001-03-19	Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative its salts and their solvates
NO302216B1 (no)	1998-02-09	Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen
AU4718093A (en)	1994-03-03	Substituted amines as tachykinin receptor antagonists
HUP9801323A3 (en)	1999-09-28	Use of benzotiophene derivatives for producing pharmaceutical compositions a for inhibiting cell-cell adhesion
HUP0004008A3 (en)	2002-03-28	Polymorphic form of a morpholine derivative having tachykinin receptor antagonist activity and pharmaceutical compositions containing the same
HU912921D0 (en)	1992-01-28	Cck antagonist 3-aryl-4(3h)-quinazolinones and pharmaceutical preparatives containing said compounds
IL101858A0 (en)	1992-12-30	Pharmaceutical compositions containing a combination of an angiotensin-ii antagonist and a calcium channel blocker
HUT74746A (en)	1997-02-28	Pharmaceutical compositions containing p antagonist
PL330195A1 (en)	1999-04-26	Antagonist of dopamine d4 receptor
DK92286A (da)	1986-09-02	Farmaceutisk praeparat indeholdende en histamin h2-receptorantagonist
ZA943593B (en)	1995-02-13	Pharmaceutical composition of a 5-HT3 receptor antagonist for rectal administration
FI944534L (fi)	1995-03-31	Rapamysiinikoostumuksia oraalisesti annettaviksi
FI944535L (fi)	1995-03-31	Rapamysiinikoostumuksia oraalisesti annettaviksi
IL102372A0 (en)	1993-01-14	Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
AU1919992A (en)	1993-01-08	Angiotensin ii receptor antagonist thiazole devivatives
EP0467365A3 (en)	1993-02-17	Use of a 5-hydroxytryptamine-3(5-ht3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence